Form 8-K - Current report:
SEC Accession No. 0001193125-20-075484
Filing Date
2020-03-17
Accepted
2020-03-17 08:01:04
Documents
3
Period of Report
2020-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d883597d8k.htm 8-K 19901
2 EX-10.1 d883597dex101.htm EX-10.1 451416
3 EX-10.2 d883597dex102.htm EX-10.2 247579
  Complete submission text file 0001193125-20-075484.txt   720162
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 20719287
SIC: 2834 Pharmaceutical Preparations